11.46
+0.45(+4.09%)
Currency In USD
| Previous Close | 11.01 |
| Open | 11.03 |
| Day High | 11.58 |
| Day Low | 11.03 |
| 52-Week High | 37.13 |
| 52-Week Low | 6.32 |
| Volume | 483,796 |
| Average Volume | 782,926 |
| Market Cap | 471.2M |
| PE | -13.02 |
| EPS | -0.88 |
| Moving Average 50 Days | 10.27 |
| Moving Average 200 Days | 12.32 |
| Change | 0.45 |
If you invested $1000 in RxSight, Inc. (RXST) since IPO date, it would be worth $713.13 as of December 24, 2025 at a share price of $11.41. Whereas If you bought $1000 worth of RxSight, Inc. (RXST) shares 3 years ago, it would be worth $1,008.84 as of December 24, 2025 at a share price of $11.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
RxSight, Inc. Announces Chief Financial Officer Transition
GlobeNewswire Inc.
Dec 22, 2025 10:15 PM GMT
ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Compan
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
GlobeNewswire Inc.
Nov 20, 2025 9:05 PM GMT
ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today anno
RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025
GlobeNewswire Inc.
Oct 22, 2025 8:05 PM GMT
ALISO VIEJO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results